Join
Live feed
·
PRReleasevia Quantisnow
Avadel Pharmaceuticals plc logo

Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch

ByQuantisnow·Wall Street's wire, on your screen.
AVDL· Avadel Pharmaceuticals plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AVDL (Avadel Pharmaceuticals plc) and more on Quantisnow.